Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs

Journal of Pineal Research

Volumn 57, Issue 1, 2014, Pages 33-42

  Herrera, Emilio A ^a,b   Macchiavello, Roberto ^a   Montt, Camilo ^a   Ebensperger, Germán ^a   Díaz, Marcela ^a   Ramírez, Santiago ^a   Parer, Julian T ^c   Serõn Ferré, María ^a   Reyes, Roberto V ^a,b   Llanos, Aníbal J ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cerebral circulation; chronic hypoxia; melatonin; neonate; nitric oxide; oxidative stress

Indexed keywords

MELATONIN; METHACHOLINE; POTASSIUM; SEROTONIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTERIAL PRESSURE; ARTICLE; BIOMETRY; BLOOD VESSEL REACTIVITY; BRAIN CIRCULATION; BRAIN HISTOLOGY; BRAIN HYPOXIA; BRAIN PERFUSION; CARDIOVASCULAR RESPONSE; CAROTID ARTERY FLOW; CONTROLLED STUDY; HEART OUTPUT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MIDDLE CEREBRAL ARTERY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; OXYGEN TENSION; SYSTEMIC VASCULAR RESISTANCE; TREATMENT DURATION; ANIMAL; ANOXIA; DRUG EFFECTS; METABOLISM; SHEEP;

ANIMALS; ANOXIA; CEREBROVASCULAR CIRCULATION; MELATONIN; NITRIC OXIDE; OXIDATIVE STRESS; SHEEP;

EID: 84904506620     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12141     Document Type: Article

References (92)

1. Gunn AJ, Bennet L,. Fetal hypoxia insults and patterns of brain injury: insights from animal models. Clin Perinatol 2009; 36: 579-593.
2. Li Y, Gonzalez P, Zhang L,. Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions. Prog Neurobiol 2012; 98: 145-165.
3. Graham EM, Ruis KA, Hartman AL, et al. A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 2008; 199: 587-595.
4. Keyes LE, Armaza JF, Niermeyer S, et al. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res 2003; 54: 20-25.
5. Niermeyer S, Andrade Mollinedo P, Huicho L,. Child health and living at high altitude. Arch Dis Child 2009; 94: 806-811.
6. Schleithoff C, Voelter-Mahlknecht S, Dahmke IN, et al. On the epigenetics of vascular regulation and disease. Clin Epigenetics 2012; 4: 7.
7. Bennet L, Booth LC, Drury PP, et al. Preterm neonatal cardiovascular instability: does understanding the fetus help evaluate the newborn? Clin Exp Pharmacol Physiol 2012; 39: 965-972.
8. Baburamani AA, Lo C, Castillo-Melendez M, et al. Morphological evaluation of the cerebral blood vessels in the late gestation fetal sheep following hypoxia in utero. Microvasc Res 2013; 85: 1-9.
9. Pereyra-Peña J, Tomimatsu T, Hatran DP, et al. Cerebral blood flow and oxygenation in ovine fetus: responses to superimposed hypoxia at both low and high altitude. J Physiol 2007; 578: 359-370.
10. Lee SJ, Hatran DP, Tomimatsu T, et al. Fetal cerebral blood flow, electrocorticographic activity, and oxygenation: responses to acute hypoxia. J Physiol 2009; 587: 2033-2047.
11. Hernandez-Andrade E, Stampalija T, Figueras F,. Cerebral blood flow studies in the diagnosis and management of intrauterine growth restriction. Curr Opin Obstet Gynecol 2013; 25: 138-144.
12. Goyal R, van Wickle J, Goyal D, et al. Antenatal maternal long-term hypoxia: acclimatization responses with altered gene expression in ovine fetal carotid arteries. PLoS One 2013; 8: e82200.
13. Tissot van Patot MC, Ebensperger G, Gassmann M, et al. The hypoxic placenta. High Alt Med Biol 2012; 13: 176-184.
14. Giussani DA, Phillips PS, Anstee S, et al. Effects of altitude versus economic status on birthweight and body shape at birth. Pediatr Res 2001; 49: 490-494.
15. Gilbert RD, Pearce WJ, Longo LD,. Fetal cardiac and cerebrovascular acclimatization responses to high altitude, long-term hypoxia. High Alt Med Biol 2003; 4: 203-213.
16. Williams JM, Pearce WJ,. Age-dependent modulation of endothelium- dependent vasodilatation by chronic hypoxia in ovine cranial arteries. J Appl Physiol (1985) 2006; 100: 225-232.
17. Behringer EJ, Leite LD, Buchholz NE, et al. Maturation and long-term hypoxia alters Ca2+-induced Ca2+ release in sheep cerebrovascular sympathetic neurons. J Appl Physiol (1985) 2009; 107: 1223-1234.
18. Longo LD, Pearce WJ,. Fetal cerebrovascular acclimatization responses to high-altitude, long-term hypoxia: a model for prenatal programming of adult disease? Am J Physiol Regul Integr Comp Physiol 2005; 288: R16-R24.
19. Abramov AY, Scorziello A, Duchen MR,. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci 2007; 27: 1129-1138.
20. Giussani DA, Camm EJ, Niu Y, et al. Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One 2012; 7: e31017.
21. Pialoux V, Mounier R,. Hypoxia-induced oxidative stress in health disorders. Oxid Med Cell Longev 2012; 2012: 940121.
22. Navarro-Yepes J, Zavala-Flores L, Anandhan A, et al. Antioxidant gene therapy against neuronal cell death. Pharmacol Ther 2014; 142: 206-230.
23. Faraci FM,. Oxidative stress: the curse that underlies cerebral vascular dysfunction? Stroke 2005; 36: 186-188.
24. Faraci FM,. Reactive oxygen species: influence on cerebral vascular tone. J Appl Physiol (1985) 2006; 100: 739-743.
25. Mayberg MR,. Cerebral vasospasm. Neurosurg Clin N Am 1998; 9: 615-627.
26. Ayer RE, Zhang JH,. Oxidative stress in subarachnoid haemorraghe: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 2008; 104: 33-41.
27. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009; 31: 151-158.
28. Popa-Wagner A, Mitran S, Sivanesan S, et al. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev 2013; 2013: 963520.
29. Miller SL, Yan EB, Castillo-Meléndez M, et al. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci 2005; 27: 200-210.
30. Perrone S, Negro S, Tataranno ML, et al. Oxidative stress and antioxidant strategies in newborns. J Matern Fetal Neonatal Med 2010; 23: 63-65.
31. Reiter RJ, Tan DX, Fuentes-Broto L,. Melatonin: a multitasking molecule. Prog Brain Res 2010; 181: 127-151.
32. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
33. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
34. Fischer TW, Kleszczyński K, Hardkop LH, et al. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2'-deoxyguanosine) in ex vivo human skin. J Pineal Res 2013; 54: 303-312.
35. Koh PO,. Melatonin attenuates decrease of protein phosphatase 2A subunit B in ischemic brain injury. J Pineal Res 2012; 52: 57-61.
36. Kilic U, Yilmaz B, Ugur M, et al. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 2012; 52: 228-235.
37. Yawno T, Castillo-Melendez M, Jenkin G, et al. Mechanisms of melatonin-induced protection in the brain of late gestation fetal sheep in response to hypoxia. Dev Neurosci 2012; 34: 543-551.
38. Vornicescu C1, Boşca B, Crişan D, et al. Neuroprotective effect of melatonin in experimentally induced hypobaric hypoxia. Rom J Morphol Embryol 2013; 54: 1097-1106.
39. Wang Z, Liu D, Zhan J, et al. Melatonin improves short and long-term neurobehavioral deficits and attenuates hippocampal impairments after hypoxia in neonatal mice. Pharmacol Res 2013; 76: 84-97.
40. Alonso-Alconada D, Alvarez A, Arteaga O, et al. Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. Int J Mol Sci 2013; 14: 9379-9395.
41. Kaur C, Sivakumar V, Robinson R, et al. Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats. J Pineal Res 2013; 54: 190-206.
42. Zhou H, Wang J, Jiang J, et al. N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury. J Neurosci 2014; 34: 2967-2978.
43. Torres-Farfan C, Valenzuela FJ, Mondaca M, et al. Evidence of a role for melatonin in fetal sheep physiology: direct actions of melatonin on fetal cerebral artery, brown adipose tissue and adrenal gland. J Physiol 2008; 586: 4017-4027.
44. Erşahin M, Sehirli O, Toklu HZ, et al. Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J Pineal Res 2009; 47: 97-106.
45. Kozirõg M, Poliwczak AR, Duchnowicz P, et al. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 2011; 50: 261-266.
46. Reiter RJ, Tan DX, Paredes SD, et al. Beneficial effects of melatonin in cardiovascular disease. Ann Med 2010; 42: 276-285.
47. Jahnke G, Marr M, Myers C, et al. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999; 50: 271-279.
48. Polimeni G, Esposito E, Bevelacqua V, et al. Role of melatonin supplementation in neurodegenerative disorders. Front Biosci (Landmark Ed) 2014; 19: 429-446.
49. Herrera EA, Pulgar VM, Riquelme RA, et al. High altitude chronic hypoxia during gestation and after birth modifies cardiovascular responses in newborn sheep. Am J Physiol Regul Integr Comp Physiol 2007; 292: R2234-R2240.
50. Herrera EA, Verkerk MM, Derks JB, et al. Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats. PLoS One 2010; 5: e9250.
51. Herrera EA, Ebensperger G, Krause BJ, et al. Sildenafil reverses hypoxic pulmonary hypertension in highland and lowland newborn sheep. Pediatr Res 2008; 63: 169-175.
52. Herrera EA, Riquelme RA, Ebensperger G, et al. Long-term exposure to high-altitude chronic hypoxia during gestation induces neonatal pulmonary hypertension at sea level. Am J Physiol Regul Integr Comp Physiol 2010; 299: R1676-R1684.
53. Parrau D, Ebensperger G, Herrera EA, et al. Store-operated channels in the pulmonary circulation of high- and low-altitude neonatal lambs. Am J Physiol Lung Cell Mol Physiol 2013; 304: L540-L548.
54. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
55. Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2: 181-197.
56. Grunfeld S, Hamilton CA, Mesaros S, et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995; 26: 854-857.
57. Wakatsuki A, Okatani Y, Shinohara K, et al. Melatonin protects against ischemia/reperfusion-induced oxidative dam- age to mitochondria in fetal rat brain. J Pineal Res 2001; 31: 167-172.
58. Blanchard B, Pompon D, Ducrocq C,. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 2000; 29: 184-192.
59. Reiter RJ, Tan DX, Osuna C, et al. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000; 7: 444-458.
60. Mayo JC, Sainz RM, Antolin I, et al. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002; 59: 1706-1713.
61. Tan DX, Manchester LC, Terron MP, et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42.
62. Pozo MJ, Gomez-Pinilla PJ, Camello-Almaraz C, et al. Melatonin, a potential therapeutic agent for smooth muscle-related pathological conditions and aging. Curr Med Chem 2010; 17: 4150-4165.
63. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, et al. Melatonin: nature's most versatile biological signal? FEBS J 2006; 273: 2813-2838.
64. Zawilska JB, Skene DJ, Arendt J,. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep 2009; 61: 383-410.
65. Chucharoen P, Chetsawang B, Putthaprasart C, et al. The presence of melatonin receptors and inhibitory effect of melatonin on hydrogen peroxide-induced endothelial nitric oxide synthase expression in bovine cerebral blood vessels. J Pineal Res 2007; 43: 35-41.
66. Kwon KJ, Kim JN, Kim MK, et al. Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection. J Pineal Res 2011; 50: 110-123.
67. Leffler CW, Parfenova H, Jaggar JH,. Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol 2011; 301: H1-H11.
68. Northington FJ, Tobin JR, Harris AP, et al. Developmental and regional differences in nitric oxide synthase activity and blood flow in the sheep brain. J Cereb Blood Flow Metab 1997; 17: 109-115.
69. Miyawaki T, Sohma O, Mizuguchi M, et al. Development of endothelial nitric oxide synthase in endothelial cells in the human cerebrum. Brain Res Dev Brain Res 1995; 89: 161-166.
70. Nakata M, Anno K, Sugino N, et al. Effect of intrauterine ischemia-hypoxia on endothelial nitric oxide synthase in fetal brain in rats. Biol Neonate 2002; 82: 117-121.
71. Gonzalez-Barrios JA, Escalante B, Valdés J, et al. Nitric oxide and nitric oxide synthases in the fetal cerebral cortex of rats following transient uteroplacental ischemia. Brain Res 2002; 945: 114-122.
72. Wood CE, Chen GF, Keller-Wood M,. Expression of nitric oxide synthase isoforms is reduced in late-gestation ovine fetal brainstem. Am J Physiol Regul Integr Comp Physiol 2005; 289: R613-R619.
73. Pearce WJ, Williams JM, White CR, et al. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries. J Appl Physiol (1985) 2009; 107: 192-199.
74. Tamura EK, Silva CL, Markus RP,. Melatonin inhibits endothelial nitric oxide production in vitro. J Pineal Res 2006; 41: 267-274.
75. Pechánová O, Zicha J, Paulis L, et al. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 2007; 561: 129-136.
76. Hung MW, Kravtsov GM, Lau CF, et al. Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia. J Pineal Res 2013; 55: 247-256.
77. Pearce WJ, Butler SM, Abrassart JM, et al. Fetal Cerebral Oxygenation: the Homeostatic Role of Vascular Adaptations to Hypoxic Stress (Chapter 30). In: Oxygen Transport to Tissue XXXII, Advances in Experimental Medicine and Biology., LaManna JC, Puchowicz MA, Xu K, et al. eds., Springer Science+Business Media, LLC, New York, NY, 2011; pp. 225-232.
78. Thakor AS, Herrera EA, Seron-Ferre M, et al. Melatonin and vitamin C increase umbilical blood flow via nitric oxide-dependent mechanisms. J Pineal Res 2010; 49: 399-406.
79. Morris CJ, Aeschbach D, Scheer FA,. Circadian system, sleep and endocrinology. Mol Cell Endocrinol 2012; 349: 91-104.
80. Carloni S, Perrone S, Buonocore G, et al. Melatonin protects from long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008; 44: 157-164.
81. Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50: 756-760.
82. Fulia F, Gitto E, Cuzzocrea S, et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001; 31: 343-349.
83. Aversa S, Pellegrino S, Barberi I, et al. Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J Matern Fetal Neonatal Med 2012; 25: 207-221.
84. Watts JL, Milner R, Zipursky A, et al. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. Eur Respir J 1991; 4: 188-190.
85. Berger TM, Frei B, Rifai N, et al. Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res 1998; 43: 719-726.
86. Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006; 367: 1145-1154.
87. Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010; 362: 1282-1291.
88. Reiter RJ, Sainz RM, Lopez-Burillo S, et al. Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann N Y Acad Sci 2003; 993: 35-47.
89. Reiter RJ, Tan DX, Leon J, et al. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood) 2005; 230: 104-117.
90. Tütüncüler F, Eskiocak S, Başaran UN, et al. The protective role of melatonin in experimental hypoxic brain damage. Pediatr Int 2005; 47: 434-439.
91. Robertson NJ, Faulkner S, Fleiss B, et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain 2013; 136: 90-105.
92. Saugstad OD,. Oxidative stress in the newborn: a 30-year perspective. Biol Neonate 2005; 88: 228-236. Tecnológico Tecnológico Tecnológico Tecnológico